Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Nutrition & Biosciences USA has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 6 distinct examiners and 5 distinct art units, indicating broad examiner coverage with limited technical grouping overlap.
PACKARD, BENJAMIN J is the busiest examiner, with 1 pending matter. Counsel can use centralized review to maintain consistent scientific terminology and claim support, while adapting each response to its particular examiner and art-unit setting.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| Double-patenting + other | 3 (50%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PACKARD, BENJAMIN J | 1 | 67.0% | +15.3% |
| LAU, JONATHAN S | 1 | 63.8% | -17.1% |
| HOERNER, PAUL ELLSWORTH | 1 | 51.2% | +62.5% |
| GALSTER, SAMUEL LEONARD | 1 | 51.2% | +40.2% |
| WORRELL, KEVIN | 1 | 12.7% | -4.0% |
| EASHOO, MARK | 1 | 36.8% | +36.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18661777 | POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA (1-->2) LINKAGES AND USE OF THE SAME | GALSTER, SAMUEL LEONARD | — |
| 18640023 | POLYURETHANE POLYMERS COMPRISING POLYSACCHARIDES | WORRELL, KEVIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19117709 | COMPOSITIONS COMPRISING WATER, CATIONIC ALPHA-1,6-GLUCAN ETHER, AND ORGANIC SOLVENT | PACKARD, BENJAMIN J | — |
| 18716169 | COMPOSITIONS COMPRISING CATIONIC ALPHA-GLUCAN ETHERS IN AQUEOUS POLAR ORGANIC SOLVENTS | HOERNER, PAUL ELLSWORTH | — |
| 18661777 | POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA (1-->2) LINKAGES AND USE OF THE SAME | GALSTER, SAMUEL LEONARD | — |
| 18557601 | COMPOSITIONS COMPRISING OXIDIZED INSOLUBLE ALPHA-GLUCAN | EASHOO, MARK | — |
| Art Unit | Apps |
|---|---|
| 1693 | 2 |
| 1612 | 1 |
| 1611 | 1 |
| 1789 | 1 |
| 1742 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19117709 | COMPOSITIONS COMPRISING WATER, CATIONIC ALPHA-1,6-GLUCAN ETHER, AND ORGANIC SOLVENT | PACKARD, BENJAMIN J | 1612 | §103DP | Non-Final OA | — | Pending | Apr 02, 2025 |
| 18772616 | PROCESS FOR MAKING POLYACRYLONITRILE FIBERS | LAU, JONATHAN S | 1693 | §103Other | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18716169 | COMPOSITIONS COMPRISING CATIONIC ALPHA-GLUCAN ETHERS IN AQUEOUS POLAR ORGANIC SOLVENTS | HOERNER, PAUL ELLSWORTH | 1611 | §103DP | Non-Final OA | — | Pending | Jun 04, 2024 |
| 18661777 | POLYPEPTIDES CAPABLE OF PRODUCING GLUCANS HAVING ALPHA (1-->2) LINKAGES AND USE OF THE SAME | GALSTER, SAMUEL LEONARD | 1693 | §102§103Other | Non-Final OA | — | Pending | May 13, 2024 |
| 18640023 | POLYURETHANE POLYMERS COMPRISING POLYSACCHARIDES | WORRELL, KEVIN | 1789 | §103§112 | Final Rejection | — | Pending | Apr 19, 2024 |
| 18557601 | COMPOSITIONS COMPRISING OXIDIZED INSOLUBLE ALPHA-GLUCAN | EASHOO, MARK | 1742 | §103§112DP | Non-Final OA | — | Pending | Oct 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNutrition & Biosciences USA has 6 pending office actions as of November 2026, spread across 5 art units and 6 examiners.
Benjamin J Packard has the most, with 1 of Nutrition & Biosciences USA's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.